Federal Register / Vol. 71, No. 226 / Friday, November 24, 2006 / Notices 67883 

Dated: November 16, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–9385 Filed 11–22–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel, Revised Unsolicited 

Complement Program Project Review. 

Date: December 12, 2006. 

Time: 1 p.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge 6700, 6700B Rockledge Drive, 

Room 3118, Bethesda, MD 20817, (Telephone 

Conference Call). 

Contact Person: Quirjin Vos, PhD, 

Scientific Review Administrator, Scientific 

Review Program, Division of Extramural 

Activities, NIAID/NIH/DHHS, 6700B 

Rockledge Drive, MSC 7616, Bethesda, MD 

20892, 301–451–2666, qvos@niaid.nih.gov. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel, Clinical Trial for 

Community-Acquired Methicillin Resistant 

Staphylococcus Aureus Infections. 

Date: December 18, 2006. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Holiday Inn Georgetown, 2101 

Wisconsin Avenue, NW., Washington, DC 

20007. 

Contact Person: Lynn Rust, PhD., Scientific 

Review Administrator, Scientific Review 

Program, Division of Extramural Activities, 

National Institutes of Health/NIAID, 6700B 

Rockledge Drive, MSC 7616, Bethesda, MD 

20892, 301–402–3938, lr228v@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Alergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: November 16, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–9382 Filed 11–22–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meeting 

Notice is hereby given of a change in 

the meeting of the National Institute on 

Aging Special Emphasis Panel, 

December 4, 2006, 7 p.m. to December 

5, 2006 6 p.m. Holiday Inn Chevy 

Chase, 5520 Wisconsin Avenue, Chevy 

Chase, MD 20815 which was published 

in the Federal Register on November 3, 

2006, Vol. 71/64730. 

The meeting will now be held at the 

Hilton San Diego Airport Hotel, San 

Diego, California from December 4–5, 

2006. The meeting is closed to the 

public. 

Dated: November 16, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–9386 Filed 11–22–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Director, National 

Institutes of Health; Amended Notice 

of Meeting 

Notice is hereby given of a change in 

the meeting of the Recombinant DNA 

Advisory Committee, December 5, 2006, 

8 a.m. to December 6, 2006, 6 p.m., 

National Institutes of Health, Building 

31, 31 Center Drive, Bethesda, MD 

20892 which was published in the 

Federal Register on November 13, 2006, 

71 FR 218, page 66180. 

The meeting of the Recombinant DNA 

Advisory Committee will begin on 

December 5 at 12 noon and will end 

December 6, 2006 at 6 p.m. instead of 

8 a.m. to 6 p.m. The meeting is open to 

the public. 

Dated: November 16, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–9387 Filed 11–22–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflict: Skeletal Muscle and Exercise 

Physiology. 

Date: November 28, 2006. 

Time: 1 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: John P. Holden, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4016J, 

MSC 7814, Bethesda, MD 20892, 301–496–

8551. holdenjo@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Clinical 

Neuroscience and Disease. 

Date: November 28, 2006. 

Time: 3 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Rene Etcheberrigaray, MD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5196, 

MSC 7846, Bethesda, MD 20892, (301) 435–

1246, etcheber@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 


cprice-sewell on PROD1PC66 with NOTICES